Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 11.5% of Armstrong World Industries Inc.'s common stock.

BlackRock, Inc. has disclosed an increased beneficial ownership of 14.4% in Albany International Corp.'s Class A Stock, holding 4,334,115 shares as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 13.6% in Azenta, Inc.'s common stock, totaling 6,207,457 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 11.0% of Assured Guaranty Ltd.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an Amendment No. 8 to its Schedule 13G, disclosing a beneficial ownership of 11.0% in Fresh Del Monte Produce Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.7% beneficial ownership stake in Hilltop Holdings Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 9.9% of Shoe Carnival Inc.'s common stock as of June 30, 2025.

BlackRock, Inc. has disclosed an increased beneficial ownership of 14.7% in COPT Defense Properties, holding over 16.6 million shares as a passive investment.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 9.9% of Equity Residential's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.1% beneficial ownership stake in CONMED Corp's common stock as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% beneficial ownership stake in Madison Square Garden Sports Corp.'s Class A Stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 14.5% beneficial ownership stake in Adtalem Global Education Inc., totaling 5,197,028 shares.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 14.9% of Calix, Inc.'s common stock.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.4% beneficial ownership stake in Apartment Investment & Management Co., held for ordinary course of business purposes.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.0% beneficial ownership stake in FIGS, Inc.'s Class A Stock, totaling 7,756,192 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.3% of Construction Partners, Inc.'s Class A Stock.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 15.0% in Knowles Corp's common stock, totaling 13,082,127 shares.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 6.5% in Companhia de Saneamento Basico do Estado de Sao Paulo-SABESP.

BlackRock, Inc. has filed an Amendment No. 20 to its Schedule 13G, disclosing a 14.5% beneficial ownership stake in SM Energy Co, totaling 16,608,457 shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in Embecta Corp.'s common stock as of June 30, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 6.7% beneficial ownership stake in Postal Realty Trust, Inc.'s Class A Stock as of June 30, 2025.

BlackRock, Inc. has reported a significant beneficial ownership of 14.7% in Advanced Energy Industries Inc., holding over 5.5 million shares of common stock.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in STEM, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.9% beneficial ownership stake in EPLUS INC as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.6% of Nektar Therapeutics' common stock as of June 30, 2025.

BlackRock, Inc. has reported a significant beneficial ownership stake of 14.4% in Mesa Laboratories Inc., holding 782,950 shares of common stock.

BlackRock, Inc. has disclosed an amended passive ownership stake of 4.8% in Rocket Lab Corp, reducing its beneficial ownership to below the 5% threshold.

BlackRock, Inc. has filed an updated Schedule 13G, revealing a 14.4% beneficial ownership stake in Helmerich & Payne, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.0% beneficial ownership stake in X4 Pharmaceuticals, Inc. as of June 30, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.6% in TransMedics Group, Inc., totaling 4,955,262 shares of common stock.